Established in 1962, the Fellowships is one of UICC's oldest and most established portfolio of programmes.
Established in 1962, the Fellowships programme is one of UICC's oldest and most established initiative. Whilst it has developed and adapted over time, the programme's objective remains the same: to strengthen workforce capacity in cancer control by facilitating the exchange of knowledge, expertise and technical skills in cancer prevention, early detection and diagnosis, treatment and palliative care. UICC Fellowships also enable networking and collaboration across institutions and countries.
Enabling the exchange of knowledge, skills and techniques for cancer control through two weeks to two month international visits.
Destinées aux personnels de santé travaillant dans le domaine du cancer basés en Afrique francophone, une visite d’un mois pour acquérir de nouvelles compétences et renforcer des collaborations.
Supporting individuals from UICC member organisations to obtain expert learning and guidance in cancer control via a series of facilitated one-to-one video calls.
Training of postdoctoral and clinical cancer researchers through three-month international collaborative projects.
The UICC Fellowships programme support individuals from all over the world, and from all areas of cancer control. Over 4,000 fellowships have been awarded to date.
Learn more about the long-term impacts of the Fellowships programme
2024 dates to be confirmed
From two weeks to two months
2,200 to 5,800 USD
Master's Degree or medical equivalent
1 January- 31 December 2024
Four one-hour video calls
Cancer control professionals working in a UICC member organisation
English, French or Spanish
Each of the Fellowships programmes is supported by a pool of external reviewers, international experts across all fields of cancer control. Each application is reviewed by a minimum of two reviewers, and a final decision is made by the respective Programme Chair.
UICC would like to acknowledge and thank the Programme Chairs and reviewers for their time and dedication.
2023 Programme chairs and review committees (PDF)
In August 2023, UICC expressed its sincere thanks to Profs. Nicol Keith and Rob Jones with awards to acknowledge well over a decade of dedicated service as the Programme Chairs of the UICC Technical Fellowships programme.
In 2023, in addition to the partners below, Fellowships were supported through the Unitaid-funded SUCCESS project, UICC’s Breast Cancer programme and World Cancer Day
Founded in 1951 to support cancer research, the Swedish Cancer Society is an independent non-profit organization with the vision of finding cures for cancer. The overall aim of the Society is to achieve a higher survival rate and a reduction in the incidence of cancer. Their main task is to raise and distribute money for cancer research. As one of the largest financiers of cancer research in Sweden, the Swedish Cancer Society essentially acts as a national research council. Thanks to the organization’s extensive knowledge about cancer, the Swedish Cancer Society is also active in areas such as public opinion and spreading knowledge about cancer, as well as results of cancer research.
Founded in 1936, the Cancer Society of Finland is the largest patient and public health organisation in Finland as well as being an expert organisation nationally. The aim of CSF is to prevent cancer, promote health and ensure a good quality of life for people with cancer. The CSF comprises of 12 regional cancer societies and six national patient organisations. The CSF’s member societies are independent actors that adhere to commonly agreed values and working principles. Activities are based on the results of scientific research, which is funded through grants offered by the Cancer Foundation Finland sr and the Foundation for the Finnish Cancer Institute sr. The Finnish Cancer Registry is a statistical and epidemiological cancer research institute that has run a database of all cases of cancer in Finland since 1952.
The Japan National Committee for UICC is a group of Japanese organisations that are members of the Union for International Cancer Control (UICC), gathered to support the UICC to strive to realise the World Cancer Declaration. Currently UICC-Japan is composed of 29 full Japanese UICC members, including major cancer specialists in Japan, cancer centres, research institutes, research funds, hospitals and cancer associations.
National Cancer Centre (NCC) was established in 2000. It strives to improve national health and welfare by reducing the incidence and mortality of cancer through research, patient care, education & training, and support for the national cancer control programs. "Vision 2020" is a program that represents the organizations goals into the future, where it fights to protect the Korean people from cancer through innovative research, quality medical care, optimal training of cancer experts, and support for national cancer control programs.
The mission of the Prevent Cancer Foundation® is saving lives across all populations through cancer prevention and early detection. The Prevent Cancer Foundation® is one of the leading voluntary health organizations in the U.S. and the only U.S. non-profit focused solely on cancer prevention and early detection. Founded in 1985, it has catapulted cancer prevention to prominence and fulfils its mission through research, education, outreach and advocacy. The Foundation’s vision is to Stop Cancer Before It Starts!®
Princess Margaret Hospital (PMH), a teaching hospital of the University of Toronto, has achieved an international reputation as a global leader in the fight against cancer and is considered one of the top comprehensive cancer treatment and research centres in the world. PMH and its research arm, the Ontario Cancer Institute work with a clinical and research staff at which represents many of the world's leading experts in oncology. It prides itself on building caring relationships with its patients. With each patient case, they combine state-of-the art diagnosis and treatment with compassion and care. PMH was accepted as a full UICC member in 1992.
For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bring forward medicines and vaccines for the world’s most challenging diseases. MSD is a trade name of Merck & Co., Inc., Kenilworth, N.J., USA. Through their prescription medicines, vaccines, biologic therapies, and animal health products, they work with customers and operate in more than 140 countries to deliver innovative health solutions. MSD also demonstrates their commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola.
Virtual Fellowships allow cancer professionals from UICC member organisations to obtain expert learning and guidance in cancer control in English, French or Spanish, through a series of four one-to-one video calls with experts.
Transfer of cancer control knowledge, skills and techniques through one month international visits
En 2017 UICC a lancé un programme de bourses pour le personnel de santé et les autres professionnels travaillant dans le domaine du cancer en Afrique francophone.
The YY Study Grants provide an important opportunity to advance cancer research through international collaboration.
In the last 50 years UICC has awarded over 4000 fellowships to cancer professionals from over 140 different countries.
Fellows who have successfully completed a fellowship are invited to join the Association of UICC Fellows.
UICC regularly reviews its capacity building programmes to ensure UICC programmes are not only contemporary but also targeted to meet the emerging needs of cancer control organisations and contribute to the development of cancer control at a country level.
Fostering an influential cancer community with the skills, knowledge, networks and resources to achieve effective cancer prevention and control.
UICC has been supporting the continuing education of cancer control professionals through online learning since 2014.
UICC has a long history of building capacity for cancer organisations globally through grant making.
The UICC's organisational leadership workstream is designed to provide leaders in cancer organisations at all levels with spaces to acquire new skills, and opportunities to collaborate and take action together.
UICC’s Cancer Advocates programme provides an opportunity for civil society organisations (CSOs) from low- and middle-income countries to gain the skills and knowledge to engage in national advocacy efforts for improved cancer control. The programme is available in English, French and Spanish.
UICC's Virtual Dialogues provide members, and the cancer community, with regular opportunities to connect, exchange knowledge, access expert insights, and share solutions from the comfort of one's office or home.
Launched in 2018, the Patient Group Mentoring programme is a tailored mentorship programme dedicated to building capacity of a representative cohort of patient groups at the regional level.
Share this page